These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 393165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli.
    Perlin MH, Lerner SA.
    Antimicrob Agents Chemother; 1982 Jul; 22(1):78-82. PubMed ID: 6289743
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase.
    Lambert T, Gerbaud G, Courvalin P.
    Antimicrob Agents Chemother; 1988 Jan; 32(1):15-9. PubMed ID: 2831812
    [Abstract] [Full Text] [Related]

  • 6. Plasmid-medicated aminoglycoside phosphotransferase of broad substrate range that phosphorylates amikacin.
    Courvalin P, Davies J.
    Antimicrob Agents Chemother; 1977 Apr; 11(4):619-24. PubMed ID: 856013
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overproduction of 3'-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli.
    Menard R, Molinas C, Arthur M, Duval J, Courvalin P, Leclercq R.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):78-83. PubMed ID: 8381641
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV, Hamilton-Miller JM, Brumfitt W.
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S, Vera D, Ramírez-Ronda CH.
    Am J Med; 1986 Jun 30; 80(6B):65-70. PubMed ID: 3014877
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin.
    Hull R, Klinger JD, Moody EE.
    J Gen Microbiol; 1976 Jun 30; 94(2):389-94. PubMed ID: 781182
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-level amikacin resistance in Pseudomonas aeruginosa associated with a 3'-phosphotransferase with high affinity for amikacin.
    Torres C, Perlin MH, Baquero F, Lerner DL, Lerner SA.
    Int J Antimicrob Agents; 2000 Aug 30; 15(4):257-63. PubMed ID: 10929874
    [Abstract] [Full Text] [Related]

  • 16. Transferable amikacin resistance in gram-negative bacterial isolates.
    Kallová J, Macicková T, Majtánová A, Aghová A, Adam D, Kettner M.
    Chemotherapy; 1995 Aug 30; 41(3):187-92. PubMed ID: 7656664
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y, Hu Y.
    Microb Drug Resist; 2012 Feb 30; 18(1):42-6. PubMed ID: 22066787
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.
    John JF, McNeill WF, Price KE, Kresel PA.
    Antimicrob Agents Chemother; 1982 Apr 30; 21(4):587-91. PubMed ID: 7044303
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.